The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans
- 1 July 1998
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 115 (1), 67-74
- https://doi.org/10.1016/s0016-5085(98)70366-x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Mitochondrial damage: a possible mechanism of the “topical” phase of NSAID induced injury to the rat intestineGut, 1997
- Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylationArthritis & Rheumatism, 1996
- FK506 increases permeability in rat intestine by inhibiting mitochondrial functionGastroenterology, 1995
- Intestinal permeability: An overviewGastroenterology, 1995
- A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver TransplantationNew England Journal of Medicine, 1994
- Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejectionThe Lancet, 1994
- Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humansGastroenterology, 1993
- Mitochondrial dysfunction in alcoholic patients as assessed by breath analysisHepatology, 1993
- The Movement of Solutes and Cells across Tight JunctionsaAnnals of the New York Academy of Sciences, 1992
- Kidney transplantation under FK 506JAMA, 1990